Extremely Marginal Liver Grafts From Deceased Donors Have Outcome Similar to Ideal Grafts

被引:34
|
作者
Goldaracena, N. [1 ]
Quinonez, E. [1 ]
Mendez, P.
Anders, M. [2 ,3 ]
Orozco Ganem, F. [2 ,3 ]
Mastai, R. [2 ,3 ]
McCormack, L. [1 ]
机构
[1] Hosp Aleman Buenos Aires, Liver Surg & Transplantat Unit, Buenos Aires, DF, Argentina
[2] Hosp Aleman Buenos Aires, Serv Hepatol, Buenos Aires, DF, Argentina
[3] Hosp Aleman Buenos Aires, Transplantat Unit, Buenos Aires, DF, Argentina
关键词
SINGLE-CENTER EXPERIENCE; EXPANDED CRITERIA; LIVING DONOR; TRANSPLANTATION; RECIPIENTS; ARGENTINA; PROVIDE; MODEL;
D O I
10.1016/j.transproceed.2012.07.113
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although there is a worldwide need to expand the donor pool, many cadaveric marginal livers are usually discarded for transplantation. Herein, we report the outcome of a series of patients receiving marginal grafts. Methods. We analyzed all patients who underwent liver transplantation in our unit from August 2006 to March 2011 (n = 125) with the use of a prospectively collected database. Patients with >= 3 of donor (prolonged hypotensive episodes, donor age >55 years, high vasopressor drug requirement, hypernatremia, prolonged intensive care unit stay, elevated transaminases) and graft-related (cold ischemia >12 hours, warm ischemia time >40 minutes and steatosis >30%) extended criteria were defined as extremely marginal liver grafts (EMLG). The outcomes of patients receiving EMLG were compared with the recipients of grafts without any marginal criteria (ideal grafts). Results. The EMLG group (n = 36) showed higher operative transfusion requirement (66.6% vs 55.6%) as well as 30-day (11.1% vs 55%) and 1-year (22.2% vs 5.5%) mortality rates, compared with the ideal grafts group (n = 18) but without a significant difference. Other variables, such as major complications, postoperative hemodialysis, ICU and hospital stay, and 1-year survival also were not significantly different. Conclusions. The liver pool can be safely expanded using EMLG from deceased donors for liver transplantation. These usually discarded liver grafts showed similar early and long-term outcomes compared with ideal organs.
引用
收藏
页码:2219 / 2222
页数:4
相关论文
共 50 条
  • [41] The use of liver grafts from donors with bacterial meningitis
    Satoi, S
    Bramhall, SR
    Solomon, M
    Hastings, M
    Mayer, AD
    de Goyet, JD
    Buckels, JAC
    McMaster, P
    Mirza, DF
    TRANSPLANTATION, 2001, 72 (06) : 1108 - 1113
  • [42] COMPARISON OF SURVIVAL IN RECIPIENTS OF DECEASED DONOR LIVER GRAFTS WITH RECIPIENTS OF LIVING DONOR LIVER GRAFTS
    Bauschke, A.
    Hofmann, A. A.
    Ali-Deeb, A.
    Bunz, K.
    Kissler, H.
    Malessa, C.
    Tautenhahn, H-M.
    Settmacher, U.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 51 - 52
  • [43] Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016
    Haugen, Christine E.
    Holscher, Courtenay M.
    Luo, Xun
    Bowring, Mary Grace
    Orandi, Babak J.
    Thomas, Alvin G.
    Garonzik-Wang, Jacqueline
    Massie, Allan B.
    Philosophe, Benjamin
    McAdams-DeMarco, Mara
    Segev, Dorry L.
    JAMA SURGERY, 2019, 154 (05) : 441 - 449
  • [44] FEASIBILITY OF USING GRAFTS FROM MARGINAL DONORS IN LIVER RETRANSPLANTATION. A SINGLE-CENTER ANALYSIS
    Marti, Josep
    Fondevila, Constantino
    Marta Modolo, Maria
    Calatayud, David
    Sanchez, Santiago
    Ferrer, Joana
    Garcia-Roca, Raquel
    Fuster, Josep
    Carlos Garcia-Valdecasas, Juan
    TRANSPLANT INTERNATIONAL, 2009, 22 : 203 - 204
  • [45] FEASIBILITY OF USING GRAFTS FROM MARGINAL DONORS IN LIVER RETRANSPLANTATION. A SINGLE-CENTER ANALYSIS
    Marti, Josep
    Fondevila, Constantino
    Marta Modolo, Maria
    Calatayud, David
    Sanchez, Santiago
    Ferrer, Joana
    Garcia-Roca, Raquel
    Fuster, Josep
    Carlos Garcia-Valdecasas, Juan
    LIVER TRANSPLANTATION, 2009, 15 (07) : S212 - S212
  • [46] Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
    Fujii, Yuki
    Kawamura, Norio
    Zaitsu, Masaaki
    Watanabe, Masaaki
    Goto, Ryoichi
    Kamiyama, Toshiya
    Taketomi, Akinobu
    Shimamura, Tsuyoshi
    ANNALS OF TRANSPLANTATION, 2020, 25
  • [47] Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors
    Choi, YoungRok
    Choi, Jong Young
    Yi, Nam-Joon
    Lee, Kyoungbun
    Mori, Shozo
    Hong, Geun
    Kim, Hyeyoung
    Park, Min-Su
    Yoo, Tae
    Suh, Suk-Won
    Lee, Hae Won
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    TRANSPLANT INTERNATIONAL, 2013, 26 (12) : 1173 - 1183
  • [48] Ameliorating the acceptance of liver grafts donors
    Briceno, J
    delaMata, M
    LopezCillero, P
    Rufian, S
    Alba, F
    Castilla, J
    Espinosa, E
    Solorzano, G
    Diaz, C
    Padillo, J
    Pera, C
    HEPATOLOGY, 1996, 24 (04) : 1189 - 1189
  • [49] Living liver donors for late retransplantation: Analysis of outcome based on preoperative prognostic scores between deceased and living donor liver grafts.
    Troisi, R
    Sainz-Barriga, M
    Ricciardi, S
    Berrevoet, F
    De Gendt, S
    De Hemptinne, B
    LIVER TRANSPLANTATION, 2006, 12 (05) : C35 - C35
  • [50] Hydroxyectoine ameliorates preservation injury in deceased after cardiac death donors in experimental liver grafts
    Srinivasan, Pramod Kadaba
    Fet, Ngwi
    Bleilevens, Christian
    Afify, Mamdouh
    Doorschodt, Benedict
    Yagi, Shintaro
    van Echten-Deckert, Gerhild
    Tolba, Rene Hany
    ANNALS OF TRANSPLANTATION, 2014, 19